Nomogram to assess survival benefit of new over historical agents as salvage therapy for metastatic urothelial carcinoma (mUC) in non-randomized trials Meeting Abstract
| Authors: | Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Choueiri, T. K.; Bellmunt, J.; Regazzi, A. M.; Mullane, S. A.; Necchi, A.; Raggi, D.; Lee, J. L.; Lee, S. I.; Simpson, J.; Derleth, C. L.; Shih-Wen, L.; Bajorin, D. F. |
| Abstract Title: | Nomogram to assess survival benefit of new over historical agents as salvage therapy for metastatic urothelial carcinoma (mUC) in non-randomized trials |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Language: | English |
| ACCESSION: | WOS:000411931702112 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.e16012 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e16012 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
